IL115199A - Composition comprising a polynucleic acid molecule in a liposome and method using said composition - Google Patents

Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Info

Publication number
IL115199A
IL115199A IL11519995A IL11519995A IL115199A IL 115199 A IL115199 A IL 115199A IL 11519995 A IL11519995 A IL 11519995A IL 11519995 A IL11519995 A IL 11519995A IL 115199 A IL115199 A IL 115199A
Authority
IL
Israel
Prior art keywords
composition
liposome
polynucleic acid
acid molecule
vitro
Prior art date
Application number
IL11519995A
Other languages
English (en)
Other versions
IL115199A0 (en
Original Assignee
Opperbas Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opperbas Holding Bv filed Critical Opperbas Holding Bv
Priority to IL11519995A priority Critical patent/IL115199A/xx
Publication of IL115199A0 publication Critical patent/IL115199A0/xx
Priority to PCT/IL1996/000101 priority patent/WO1997010851A2/en
Priority to US09/029,376 priority patent/US6207456B1/en
Priority to EP96929504A priority patent/EP0879062B1/de
Priority to AU68884/96A priority patent/AU703271C/en
Priority to AT96929504T priority patent/ATE219380T1/de
Priority to CA002231172A priority patent/CA2231172A1/en
Priority to DE69621953T priority patent/DE69621953T2/de
Priority to JP9512542A priority patent/JPH11514349A/ja
Publication of IL115199A publication Critical patent/IL115199A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11519995A 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition IL115199A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition
PCT/IL1996/000101 WO1997010851A2 (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle
US09/029,376 US6207456B1 (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle
EP96929504A EP0879062B1 (de) 1995-09-07 1996-09-05 Vehikel zum einbringen von nukleinsäuren in zellen
AU68884/96A AU703271C (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle
AT96929504T ATE219380T1 (de) 1995-09-07 1996-09-05 Vehikel zum einbringen von nukleinsäuren in zellen
CA002231172A CA2231172A1 (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle
DE69621953T DE69621953T2 (de) 1995-09-07 1996-09-05 Vehikel zum einbringen von nukleinsäuren in zellen
JP9512542A JPH11514349A (ja) 1995-09-07 1996-09-05 核酸デリバリー担体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Publications (2)

Publication Number Publication Date
IL115199A0 IL115199A0 (en) 1995-12-31
IL115199A true IL115199A (en) 2005-05-17

Family

ID=11067956

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Country Status (8)

Country Link
US (1) US6207456B1 (de)
EP (1) EP0879062B1 (de)
JP (1) JPH11514349A (de)
AT (1) ATE219380T1 (de)
CA (1) CA2231172A1 (de)
DE (1) DE69621953T2 (de)
IL (1) IL115199A (de)
WO (1) WO1997010851A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
DE19605548A1 (de) * 1996-02-15 1997-09-04 Boehringer Ingelheim Int Zusammensetzung für die Transfektion höherer eukaryotischer Zellen
FR2751222B1 (fr) * 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
DE19740092A1 (de) * 1997-09-12 1999-03-18 Ulrich Dr Med Hengge Liposomen und Verfahren zur Transfektion von Zellen
WO1999042091A2 (en) 1998-02-19 1999-08-26 Massachusetts Institute Of Technology Use of polycations as endosomolytic agents
US7276359B1 (en) * 1998-03-13 2007-10-02 Wyeth Polynucleotide composition, method of preparation, and use thereof
IL126681A0 (en) * 1998-10-21 1999-08-17 Opperbas Holding Bv Treatment of trauma-related conditions
EP1361862B1 (de) * 2001-02-22 2007-04-18 Opperbas Holding B.V. Durch liposome vermittelte dna verabreichung
CA2452417C (en) 2001-07-13 2013-08-20 Pepharm R & D Limited Compositions comprising the biologicially active peptide ysl
CN1210292C (zh) * 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号22的生物活性肽
MXPA05003771A (es) * 2002-10-09 2005-06-08 Pfizer Prod Inc Composiciones estabilizadas de adn desnudo.
CA2522380A1 (en) * 2003-03-19 2004-09-30 Isogenis, Inc. Specific inhibition of allorejection
TWI353252B (en) 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
CN101068574B (zh) * 2004-07-20 2012-07-18 伊索格尼斯股份有限公司 与自身抗原有关的自身免疫和疾病的特异性抑制
CN101501062B (zh) 2005-07-26 2012-07-18 康哲医药研究(深圳)有限公司 新型生物活性肽及其新用途
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US20100272769A1 (en) * 2005-08-03 2010-10-28 Amcol International Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use
JP5336853B2 (ja) 2005-11-02 2013-11-06 プロチバ バイオセラピューティクス インコーポレイティッド 修飾ｓｉＲＮＡ分子およびその使用法
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
WO2008026781A1 (fr) * 2006-08-31 2008-03-06 Astellas Pharma Inc. Vésicule de lipide à ciblage inverse
JP5484059B2 (ja) * 2006-10-06 2014-05-07 エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 脊髄核インプラント
EP2167069B1 (de) * 2007-05-23 2011-10-26 Amcol International Corporation Mit cholesterin interagierende phyllosilikate und verfahren zur reduktion von hypercholesterinämie bei einem säuger
CA2710713C (en) 2007-12-27 2017-09-19 Protiva Biotherapeutics, Inc. Silencing of polo-like kinase expression using interfering rna
EP2281041B1 (de) 2008-04-15 2014-07-02 Protiva Biotherapeutics Inc. Abdämpfen der csn5 genexpression unter verwendung von interferierender rns
US8871515B2 (en) * 2008-09-17 2014-10-28 Isogenis, Inc. Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
US20130164380A1 (en) 2010-06-17 2013-06-27 Actogenix Nv Compositions and methods for treating inflammatory conditions
WO2012106490A1 (en) 2011-02-03 2012-08-09 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
JP2014533953A (ja) 2011-11-17 2014-12-18 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 治療用ｒｎａスイッチ組成物及び使用方法
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
PT2897620T (pt) 2012-09-21 2020-09-03 Intensity Therapeutics Inc Método de tratamento de cancro
KR20170075742A (ko) 2014-10-02 2017-07-03 프로티바 바이오쎄라퓨틱스, 인코포레이티드 B형 간염 바이러스 유전자 발현을 제거하는 조성물 및 방법
CN209264567U (zh) 2015-04-09 2019-08-16 必康达 使用荧光纳米金刚石的成像系统
US20180245074A1 (en) 2015-06-04 2018-08-30 Protiva Biotherapeutics, Inc. Treating hepatitis b virus infection using crispr
WO2017019891A2 (en) 2015-07-29 2017-02-02 Protiva Biotherapeutics, Inc. Compositions and methods for silencing hepatitis b virus gene expression
US20170360815A1 (en) 2016-02-25 2017-12-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3419629A4 (de) 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. Zusammensetzungen und verfahren zum schutz gegen luftbürtige pathogene und reizmittel
US11041170B2 (en) 2016-04-04 2021-06-22 Thomas Jefferson University Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283122A (en) 1984-04-19 1994-02-01 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
EP0800830A3 (de) 1989-11-03 1999-03-17 Vanderbilt University Verfahren zur in Vivo-Verabreichung von funktionellen fremden Genen
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection

Also Published As

Publication number Publication date
CA2231172A1 (en) 1997-03-27
WO1997010851A3 (en) 1997-06-05
IL115199A0 (en) 1995-12-31
EP0879062A2 (de) 1998-11-25
AU6888496A (en) 1997-04-09
JPH11514349A (ja) 1999-12-07
DE69621953T2 (de) 2003-01-30
US6207456B1 (en) 2001-03-27
ATE219380T1 (de) 2002-07-15
WO1997010851A2 (en) 1997-03-27
AU703271B2 (en) 1999-03-25
DE69621953D1 (de) 2002-07-25
EP0879062B1 (de) 2002-06-19

Similar Documents

Publication Publication Date Title
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
ID18631A (id) Proses pembuatan asam l-amino melalui fermentasi
AU4981101A (en) Subtilisin variants
MX9703063A (es) Compuestos de ester y acido boronico, su sintesis y usos.
SI1077692T1 (en) Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
IL121046A0 (en) Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use
AU6568594A (en) Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
AR244544A1 (es) Composicion desodorante.
NZ292565A (en) Production of stabilised complement protein-3 convertase
AU4257789A (en) Electro-insertion of proteins into animal cell membranes
SE9501472D0 (sv) Truncated IGF-I
WO1997009420A3 (en) Dna sequences coding for a human metalloproteinase and variants thereof
AU8505898A (en) Nucleic acid compositions and methods of introducing nucleic acids into cells
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
IL129139A0 (en) Vertebrate smoothened proteins
HU9602894D0 (en) Non-splicing variants of gp350/220
PL320084A1 (en) Nucleic acids of amino acid type
ES2189014T3 (es) Procedimiento para insomerizacion de alcoholes alilicos.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
EP0317279A3 (de) Peptide für die Verwendung zur Reinigung von Faktor-VIII
GB9615852D0 (en) Production of amino acids and enzymes used therefor
WO1999059638A8 (en) Compositions and methods for the delivery of nucleic acid molecules

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees